H.R. 5892House115th Congress (2017-2019)Passed House

To establish an Advisory Committee on Opioids and the Workplace to advise the Secretary of Labor on actions the Department of Labor can take to address the impact of opioid abuse on the workplace.

Introduced May 21, 2018

AI-Generated Summary

Updated April 15, 2026 at 10:06 PM UTC

The bill creates an Advisory Committee on Opioids and the Workplace to help the Secretary of Labor develop policies and resources that address opioid abuse in the workplace. It aims to guide employers, workers, and related agencies on best practices, safety, and support for affected employees.

Key Provisions

  • The Secretary of Labor must set up the committee within 90 days of the law’s enactment.
  • The committee will have 19 unpaid members representing employers, workers, health‑benefit plans, and substance‑abuse experts, with a chair appointed by the Secretary.
  • Members serve three‑year terms and must disclose any organization they represent; a majority forms a quorum and decisions are made by majority vote.
  • The committee’s job is to advise on informational resources, best‑practice policies, safety impacts, productivity effects, treatment support, and legal requirements related to opioid abuse at work.
  • It must meet at least twice a year and produce a final report with recommendations for Congress and the Department of Labor.
  • The Department of Labor will provide staff support, and the Federal Advisory Committee Act applies to the committee’s operations.
  • No new money is authorized; the committee’s expenses are covered by existing Department of Labor funds.
  • Three non‑voting ex‑officio members from HHS agencies will join the committee, and the committee will dissolve three years after enactment.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

8 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

June 14, 2018

View full timeline
HouseIntro Referral

Introduced in House

May 21, 2018

HouseIntro Referral

Referred to the House Committee on Education and the Workforce.

May 21, 2018

HouseFloor

Mr. Lewis (MN) moved to suspend the rules and pass the bill.

June 13, 2018 • 3:33 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5129-5131)

June 13, 2018 • 3:33 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 5892.

June 13, 2018 • 3:33 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5129-5130)

June 13, 2018 • 3:44 PM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5129-5130)

June 13, 2018 • 3:44 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

June 13, 2018 • 3:44 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

June 14, 2018

Floor Debate

4 members

What members said about H.R. 5892 on the floor

2 Republicans2 Democrats
Suzanne Bonamici
Rep. Suzanne BonamiciD-OR-1 · Jun 13, 2018

Madam Speaker, I yield myself such time as I may consume. Madam Speaker, I rise today in support of H.R. 5892. In addition to the severe health consequences of substance use disorders, the opioid…

Jason Lewis
Rep. Jason LewisR-MN-2 · Jun 13, 2018

Madam Speaker, I move to suspend the rules and pass the bill (H.R. 5892) to establish an Advisory Committee on Opioids and the Workplace to advise the Secretary of Labor on actions the Department of…

Glenn Thompson
Rep. Glenn ThompsonR-PA-5 · Jun 14, 2018

Mr. Speaker, I rise today to highlight the efforts the House is undertaking this week to combat our Nation's opioid crisis. We will consider dozens of bills this week that are aimed at fighting the…

Matt Cartwright
Rep. Matt CartwrightD-PA-17 · Jun 13, 2018

Madam Speaker, I rise in support of H.R. 5892, a bill I am proud to have cosponsored with Representative Lewis. I thank Congressman Lewis, as well as the Education and the Workforce Committee, for…

Bill Text

3 versions available

Reading Mode
Latest
Referred in SenateIssued June 14, 2018

IIB

115th CONGRESS

2d Session

H. R. 5892

IN THE SENATE OF THE UNITED STATES

June 14, 2018

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To establish an Advisory Committee on Opioids and the Workplace to advise the Secretary of Labor on actions the Department of Labor can take to address the impact of opioid abuse on the workplace.

1.

Establishment of an Advisory Committee on Opioids and the Workplace

(a)

Establishment

Not later than 90 days after enactment of this Act, the Secretary of Labor shall establish an Advisory Committee on Opioids and the Workplace (referred to in this Act as the Advisory Committee) to advise the Secretary on actions the Department of Labor can take to provide informational resources and best practices on how to appropriately address the impact of opioid abuse on the workplace and support workers abusing opioids.

(b)

Membership

(1)

Composition

The Secretary of Labor shall appoint as members of the Advisory Committee 19 individuals with expertise in employment, workplace health programs, human resources, substance use disorder, and other relevant fields. The Advisory Committee shall be composed as follows:

(A)

Four of the members shall be individuals representative of employers or other organizations representing employers.

(B)

Four of the members shall be individuals representative of workers or other organizations representing workers, of which at least two must be representatives designated by labor organizations.

(C)

Three of the members shall be individuals representative of health benefit plans, employee assistance plan providers, workers’ compensation program administrators, and workplace safety and health professionals.

(D)

Eight of the members shall be individuals representative of substance abuse treatment and recovery experts, including medical doctors, licensed addiction therapists, and scientific and academic researchers, of which one individual may be a representative of a local or State government agency that oversees or coordinates programs that address substance use disorder.

(2)

Chair

From the members appointed under paragraph (1), the Secretary of Labor shall appoint a chairperson.

(3)

Terms

Each member of the Advisory Committee shall serve for a term of 3 years. A member appointed to fill a vacancy shall be appointed only for the remainder of such term.

(4)

Quorum

A majority of members of the Advisory Committee shall constitute a quorum and action shall be taken only by a majority vote of the members.

(5)

Voting

The Advisory Committee shall establish voting procedures.

(6)

No compensation

Members of the Advisory Committee shall serve without compensation.

(7)

Disclosure

Every member of the Advisory Committee must disclose the entity, if applicable, that he or she is representing.

(c)

Duties

(1)

Advisement

(A)

In general

The Advisory Committee established under subsection (a) shall advise the Secretary of Labor on actions the Department of Labor can take to provide informational resources and best practices on how to appropriately address the impact of opioid abuse on the workplace and support workers abusing opioids.

(B)

Considerations

In providing such advice, the Advisory Committee shall take into account—

(i)

evidence-based and other employer substance abuse policies and best practices regarding opioid use or abuse, including benefits provided by employee assistance programs or other employer-provided benefits, programs, or resources;

(ii)

the effect of opioid use or abuse on the safety of the workplace as well as policies and procedures addressing workplace safety and health;

(iii)

the impact of opioid abuse on productivity and absenteeism, and assessments of model human resources policies that support workers abusing opioids, such as policies that facilitate seeking and receiving treatment and returning to work;

(iv)

the extent to which alternative pain management treatments other than opioids are or should be covered by employer-sponsored health plans;

(v)

the legal requirements protecting employee privacy and health information in the workplace, as well as the legal requirements related to nondiscrimination;

(vi)

potential interactions of opioid abuse with other substance use disorders;

(vii)

any additional benefits or resources available to an employee abusing opioids that promote retaining employment or reentering the workforce;

(viii)

evidence-based initiatives that engage employers, employees, and community leaders to promote early identification of opioid abuse, intervention, treatment, and recovery;

(ix)

workplace policies regarding opioid abuse that reduce stigmatization among fellow employees and management; and

(x)

the legal requirements of the Mental Health Parity and Addiction Equity Act and other laws related to health coverage of substance abuse and mental health services and medications.

(2)

Report

Prior to its termination as provided in subsection (j), the Advisory Committee shall issue a report to the Secretary of Labor and to the Committee on Education and the Workforce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate, detailing successful programs and policies involving workplace resources and benefits, including recommendations or examples of best practices for how employers can support and respond to employees impacted by opioid abuse.

(d)

Meetings

The Advisory Committee shall meet at least twice a year at the call of the chairperson.

(e)

Staff support

The Secretary of Labor shall make available staff necessary for the Advisory Committee to carry out its responsibilities.

(f)

Federal Advisory Committee Act

The Federal Advisory Committee Act shall apply to the Advisory Committee established under this Act.

(g)

No appropriated funds

No additional funds are authorized to be appropriated to carry out this Act. Expenses of the Advisory Committee shall be paid with funds otherwise appropriated to Departmental Management within the Department of Labor.

(h)

Ex officio

Three nonvoting representatives from agencies within the Department of Health and Human Services whose responsibilities include opioid prescribing guidelines, workplace safety, and monitoring of substance abuse and prevention programs shall be appointed by the Secretary of Labor and designated as ex officio members.

(i)

Agenda

The Secretary of Labor or a representative of the Secretary shall consult with the Chair in establishing the agenda for Committee meetings.

(j)

Termination

The Advisory Committee established under this Act shall terminate 3 years after the date of enactment of this Act.

Passed the House of Representatives June 13, 2018.

Karen L. Haas,

Clerk.